Journal of Chinese Pharmaceutical Sciences ›› 2022, Vol. 31 ›› Issue (7): 545-555.DOI: 10.5246/jcps.2022.07.048
• Original articles • Previous Articles Next Articles
Ciyan Peng1, Jing Chen2, Sini Li3, Jianhe Li1, Liubao Peng1,*()
Received:
2022-04-23
Revised:
2022-05-12
Accepted:
2022-06-11
Online:
2022-07-31
Published:
2022-07-31
Contact:
Liubao Peng
Supporting:
Ciyan Peng, Jing Chen, Sini Li, Jianhe Li, Liubao Peng. Study of the economic burden and influencing factors on stroke patients in Central China in the post-epidemic era[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(7): 545-555.
[1] |
Liu, Z.Y.; Yao, S.F.; Dai, Y.J.; Qian, K.; Song, J.F. Screening and risk factors for stroke in middle-aged and elderly urban and rural residents. Chin. J. Gerontol. 2020, 40, 4227–4230.
|
[2] |
Sun, Y.; Liu, Y.; Zhou, W.; Xiong, Y.C. Multiple linear regression analysis of factors influencing stroke rehabilitation hospitalization costs. Jiangsu Manage Health Care. 2020, 31, 617–621.
|
[3] |
Yang, Y.; Li, S.H.; Wang, X.; Guo, Y.W.; Ma, Y.; Shi, X.F. Study on the utilization of inpatient health services and factors influencing hospitalization costs of urban stroke patients in China. Chin. Gen. Med. 2020, 23, 1615–1620.
|
[4] |
Guzik, A.; Bushnell, C. Stroke epidemiology and risk factor management. Continuum Minneap. Minn. 2017, 23, 15–39.
|
[5] |
Wang, L.D.;, Liu, J.M.; Yang, Y.; Peng, B.; Wang, Y.L. Stroke prevention and treatment in China still faces great challenges-Summary of China Stroke Prevention and Treatment Report 2018. Chin. J. Circ. 2019, 34, 105–119.
|
[6] |
Wu, S.M.; Wu, B.; Liu, M.; Chen, Z.M.; Wang, W.Z.; Anderson, C.S.; Sandercock, P.; Wang, Y.J.; Huang, Y.N.; Cui, L.Y.; Pu, C.Q.; Jia, J.P.; Zhang, T.; Liu, X.F.; Zhang, S.M.; Xie, P.; Fan, D.S.; Ji, X.M.; Zhang, S.H. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 2019, 18, 394–405.
|
[7] |
Brainin, M. Stroke epidemiology in China: which are the next steps? Lancet Neurol. 2019, 18, 325–326.
|
[8] |
Luo, L.S.; Jiang, J.F.; Yu, C.H.; Luo, B.; Nan, P.H. Analysis of hospital admissions and hospitalization costs of stroke patients over 40 years old in 184 hospitals in Shanxi Province. Chin. J. Heal. Stat. 2019, 36, 185–188.
|
[9] |
Li, Z.X.; Jiang, Y.; Li, H.; Xian, Y.; Wang, Y.J. China’s response to the rising stroke burden. BMJ Clin. Res. Ed. 2019, 364, l879.
|
[10] |
Huang, Y.; Liao, X.P.; Song, Z.T.; Wang, L.H.; Xiao, M.H.; Zhong, S.Q. Evaluation of the influence of etiological factors on the economic burden of ischemic stroke in younger patients in China using the trial of org 10172 in acute stroke treatment (TOAST) classification. Med. Sci. Monit. 2019, 25, 637–642.
|
[11] |
Huang, S.F.; Li, Y.Y.; Zhao, L.D.; Gong, T.; Lu, X.; Zhang, J. Analysis of the composition and influencing factors of hospitalization cost of patients with cerebral infarction in a Chinese hospital in Gansu Province. J. Guangzhou Univ. Tradit. Chin. Med. 2020, 37, 1012–1017.
|
[12] |
Ma, Yong. Study on medical expenses and influencing factors in stroke patients in urban residents. Beijing Univ. Tradit. Chin. Med. 2018.
|
[13] |
Wei, Y.Q.; Li, Y.M.; Li, Y.S.; Li, L.G. Path analysis of hospitalization expense and its influencing factors in patients with cerebral infarction. Chin. J. Med. Manag. Sci. 2019, 9, 16–21.
|
[14] |
Xu, Y.; Chen, Y.Y.; Yu, S.Y.; Liu, H.Y.; Qu, S.N.; Wang, Q.Q.; Wang, M.B. Analysis of the epidemiological characteristics of stroke in Yantai City between 2012 and 2015. Mod. Prev. Med. 2017, 44, 200–204.
|
[15] |
Zhou, H.Y. Study on the factors influencing and predicting hospitalization costs of insured stroke patients in Tianjin. Tianjin Med. Univ. 2016.
|
[16] |
Huang, J.; Wei, X.H.; Wu, B.Y.; Ji, Q.; Zhang, N.Y.; Ren, Y.R. A pass-through analysis of the factors influencing the total hospitalization cost of residents in China. China Health Care Manage. 2014, 31, 86–87+124.
|
[17] |
Liu, C.; Luo, L.; Duan, L.J.; Hou, S.Y.; Zhang, B.Y.; Jiang, Y. Factors affecting in-hospital cost and mortality of patients with stroke: evidence from a case study in a tertiary hospital in China. Int. J. Heal. Plan. Manag. 2021, 36, 399–422.
|
[18] |
Zhang, Q.L.; Liu, Y.; Jiang, M.; Liu, Y.; Gu, S.S.; Tong, H.W.; Liu, H.J. Temporal trends in the risk factors and clinical characteristics of ischemic stroke in young adults. J. Stroke Cerebrovasc. Dis. 2020, 29, 104914.
|
[19] |
Chen, C.; Qiao, X.Y.; Kang, H.J.; Ding, L.; Bai, L.X.; Wang, J.T. Community physicians’ knowledge of secondary prevention after ischemic stroke: a questionnaire survey in Shanxi Province, China. BMC Med. Educ. 2015, 15, 197.
|
[20] |
Yang, J.; Zhang, J.; Ou, S.; Wang, N.; Wang, J. Correction: knowledge of community general practitioners and nurses on pre-hospital stroke prevention and treatment in Chongqing, China. PLoS One. 2019, 14, e0213969.
|
[21] |
Niu, J.W.; Yuan, J.; Gao, S.; Xu, W.H. Low awareness of stroke guidelines and preference for Chinese herbs in community physicians: a national survey in China. Ann. Transl. Med. 2014, 2, 76.
|
[22] |
Cao, Y.N.; Guan, T.J.; Li, J.L.; Qu, Y.M.; Wang, B.; Liu, Y.L. A study on factors influencing hospitalization costs and prognosis of stroke patients. China Health Policy Res. 2016, 9, 54–60.
|
[23] |
Pan, M.Y.; Duan,C.Y. A study of hospitalization costs and factors influencing stroke patients in China. Electronic J. Int. Med. Cardiovasc. Dis. 2020, 8, 78–86.
|
[24] |
Zheng, L.C.; Luo, Z.M.; Chen, Y.J.; Liu, L. Study on the medical cost components and related influencing factors of acute stroke patients. Chin. J. Geriatr. Cardiovasc. Cerebrovasc. Dis. 2001, 3, 168–171.
|
[25] |
Cai, T.; Cheng, X.J.; Zhang, X.J.; Deng, S.X.; Zhong, Y.; Chen, H.L. Analysis of hospitalization costs of stroke patients with different types of insurance in Guibei, Guangxi from 2015 to 2016. Huaxia Med. 2018, 31, 39–42.
|
[26] |
Shen, X.C. Reform and exploration of building a hierarchical diagnosis and treatment system in Shanghai. China Health Resources. 2016, 19, 1–3.
|
[27] |
Lu, B.; Wang, S.; Yan, Y.W.; Tian, Q.F. Study on the factors influencing the direct economic burden of stroke patients in Henan Province. China Health Resources. 2018, 21, 417–422.
|
[28] |
Liu, X.J.; Xiao, T.; Wu, M.Y. Analysis of the current situation of medical costs of outpatients and inpatients in public hospitals in Jiangxi Province. China Health Resources. 2017, 20, 65–68.
|
[29] |
Tu, J.Y.; Ren, S.H.; Lu, B.S. Factors influencing the post-discharge destination and referral of acute stroke patients. China Rehabilitation Theory and Practice, 2017, 23, 106–109.
|
[30] |
Zheng, M.R.; Wu, J.G.; Shen, J.C.; Liu, H.; Wang, H.J.; Liao, Y.F.; Huang, J.Q.; Liu, H.Z. Analysis of hospitalization costs of stroke patients in Baiyun District, Guangzhou City, 2015. Medical Food Therapy and Health. 2019, 203–204.
|
[1] | Kexin Wang, Shengnan Tian, Jia Wang, Jin Jin, Tingting Wang, Licang Zhang, Huanlong Liu. Investigation and research on medication risk of Shijiazhuang urban residents based on KAP Theory [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 755-763. |
[2] | Wenxia Liu, Jun Ma, Zhao Yang, Bin Jiang. Influencing factors of generic drug substitution in China—from the perspective of psychiatric patients in "4 + 7" pilot cities [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(4): 317-321. |
[3] | Xin Li, Yan Shang, Mengxin Qi, Guoheng Hu. Proteomic study of Rehmannia glutinosa and Cornus officinalis herbal pair on the brain tissue of rats with ischemic stroke [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(1): 32-44. |
[4] | Yinglin Yang, Shanshan Zhang, Man Liu, Yuehua Wang, Guanhua Du. Xiao-Xu-Ming decoction extract ameliorates brain injury in rats with thrombotic focal ischemic stroke and understanding possible therapeutic targets using proteomics [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(6): 468-483. |
[5] | Jiale Li, Yan Yang, Zhaoqi Huang, Xiaolan Mo. Efficacy evaluation and influencing factors analysis of combined estrogen in the treatment of labial adhesion in children [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(12): 976-985. |
[6] | Huan Chen, Danping Zheng, Xiaoyan Liu, Yuanjun Zhu, Yinye Wang. Design, preparation and activity evaluation of two novel proteins with thrombolysis or/and neuroprotection [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(11): 787-798. |
[7] | Liang Shi, Zeng Wang, Tingting Yu, Liang Xia. Chronic disease and its therapeutic drugs may effect on the postoperative 5-year survival rate of lung cancer patients [J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(2): 147-155. |
[8] |
Zhan-Miao Yi, Fang Liu*, Suo-Di Zhai.
Efficacy and safety of fluoxetine for the treatment of post-stroke depression: a meta-analysis [J]. , 2010, 19(1): 59-66. |
[9] | Kok-Poh Loh, Wan-Hui Wong, Li-Shan Low, Hong Wang, Benny Kwong-Huat Tan, Vincent Chou, Yi-Zhun Zhu* . Mechanisms of cerebral protection of Chinese herbal extract-Braintone on middle cerebral artery occluded rats [J]. , 2009, 18(2): 106-113. |
[10] |
Shan-Hong Huang, Ranil De Silva* . Therapeutic effects of flavonoids from Ceylon green tea on hypoxic human brain epithelial cells [J]. , 2008, 17(4): 324-331. |
[11] | SUN Hong-shuo, FENG Zhong-ping*. Unbalance of the Physiological System May Cause Trouble —The Other Side of the Story from the Very Successful Drug, VIOXX [J]. , 2004, 13(4): 282-284. |
[12] | Lu Jingfen, Li Chenxu , Muteliefu Gulinuer, Li Tingfeng, Tu Pengfei, Yin Junjie, Cai Shaoqing*. Effects of BYHW Decoction and Its Effective Constituents on the Fluidity of the Cell Membrane in a Stroke-Modeled Rat Brain [J]. , 2002, 11(4): 132-136. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||